Liquiritigenin

HCID 114829CAS 578-86-9

Grundinformationen

Standard-SMILES
O=C1C[C@@H](c2ccc(O)cc2)Oc2cc(O)ccc21
InChIKey
FURUXTVZLHCCNA-AWEZNQCLSA-N
Summenformel
C15H12O4
Durchschnittliche Molmasse
256,25 g/mol
Monoisotopische Masse
256,07355886

Überblick

Liquiritigenin is a dihydroxyflavanone compound having the two hydroxy substituents at the 4'- and 7-positions. Isolated from the root of Glycyrrhizae uralensis, it is a selective agonist for oestrogen receptor beta. It has a role as a hormone agonist and a plant metabolite.

Namen und Bezeichner

Bevorzugter Name
Liquiritigenin
IUPAC
(2S)-7-hydroxy-2-(4-hydroxyphenyl)-2,3-dihydrochromen-4-one

Namen und Synonyme

Liquiritigenin578-86-9(2S)-liquiritigenin7,4'-Dihydroxyflavanone(-)-liquiritigenin(2S)-7-hydroxy-2-(4-hydroxyphenyl)-2,3-dihydrochromen-4-oneT194LKP9W6(2S)-7-Hydroxy-2-(4-hydroxyphenyl)-2,3-dihydro-4H-1-benzopyran-4-oneCHEBI:28777DTXSID902064934H-1-Benzopyran-4-one, 2,3-dihydro-7-hydroxy-2-(4-hydroxyphenyl)-, (2S)-4H-1-Benzopyran-4-one, 2,3-dihydro-7-hydroxy-2-(4-hydroxyphenyl)-, (S)-
Weitere Namen anzeigen
RefChem:41450DTXCID90128984(S)-7-Hydroxy-2-(4-hydroxyphenyl)chroman-4-one5-DEOXYFLAVANONELIQUIRTIGENINMFCD00287289(S)-liquiritigenin7-hydroxy-2-(4-hydroxy-phenyl)-chroman-4-one

Datenbank-Bezeichner

CAS
578-86-9
PubChem CID
114829
DTXSID
DTXSID90206493
ChEMBL
CHEMBL252642
ChEBI
CHEBI:28777
UNII
T194LKP9W6
Nikkaji
J22.604A

Eigenschaften

Berechnete Struktureigenschaften

XLogP
2,2
Polarare Oberfläche (TPSA)
66,8 Ų
H-Brücken-Donoren
2
H-Brücken-Akzeptoren
4
Frei drehbare Bindungen
1
Schwere Atome
19

Experimentelle und physikochemische Eigenschaften

DrugsPharmaceuticals -> Listed in ZINC15
LipidsPolyketides [PK] -> Flavonoids [PK12] -> Flavanones [PK1214]
SpringerMaterials PropertiesChemical shift
Endocrine DisruptorsPotential endocrine disrupting compound
Melting Point203 - 205 °C
Physical DescriptionSolid

Chemie und Industrie

Pharmakologische Informationen

Mechanism of Action · 1 Eintrag

MF101 promoted ERbeta, but not ERalpha, activation of an estrogen response element (ERE) upstream of the luciferase reporter gene. MF101 also selectively regulates transcription of endogenous genes through ERbeta. The ERbeta-selectivity was not due to differential binding, since MF101 binds equally to ERalpha and ERbeta. Fluorescence resonance energy transfer and protease digestion studies showed that MF101 produces a different conformation in ERalpha from ERbeta, when compared with the conformations produced by estradiol. The specific conformational change induced by MF101 allows ERbeta to bind to an ERE and recruit coregulatory proteins that are required for gene activation. MF101 did not activate the ERalpha-regulated proliferative genes, c-myc and cyclin D1, or stimulate MCF-7 breast cancer cell proliferation or tumor formation in a mouse xenograft model.

Cellular LocationsMembrane

Zugehörige Reaktionen

1

Verknüpfte Notizen

Wird geladen…